Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | COVID-19 Clinical Trials in Los Angeles | 28 Studies

Clinical Trials COVID-19Los Angeles

COVID-19 Clinical Trials in Los Angeles

Find 28 clinical trials for covid-19 near Los Angeles, California. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 28 trials

CompletedAdaptive COVID-19 Treatment Trial 3 (ACTT-3)ACTT-3 will evaluate the combination of interferon beta-1a and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized.NCT04492475·Birmingham, Alabama and 63 others

COVID-19 Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for…NCT07266558·Birmingham, Alabama and 149 others

Active not recruitingA Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of AgeThis study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine…NCT07300839·Anniston, Alabama and 195 others

CompletedConvalescent Plasma to Limit SARS-CoV-2 Associated ComplicationsTo assess the efficacy and safety of Human coronavirus immune plasma (HCIP) to reduce the risk of hospitalization or death, the duration of symptoms and duration of nasopharyngeal…NCT04373460·Birmingham, Alabama and 28 others

CompletedA Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection.NCT04470427·Birmingham, Alabama and 99 others

CompletedImmunophenotyping Assessment in a COVID-19 CohortThis surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral…NCT04378777·Tucson, Arizona and 16 others

UnknownCovid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical ConditionsThis study will provide access to investigational anti-SARS-CoV-2 human convalescent plasma for pediatric patients with underlying medical conditions (cardiovascular disease, lung…NCT04462848·Los Angeles, California

CompletedCOVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 VaccinationsBackground: Allergic reactions have been reported to occur after vaccination with both the Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine.NCT04761822·Tucson, Arizona and 28 others

UnknownPhase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19The primary objective of this study is to assess whether the use of lenzilumab in addition to current standard of care can alleviate the immune-mediated cytokine release syndrome…NCT04351152·Phoenix, Arizona and 28 others

CompletedTo Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.Substudy A: The study will evaluate the safety, tolerability, and efficacy of a booster dose of BNT162b2 when administered to participants having previously received 2 doses of…NCT04955626·Athens, Alabama and 153 others

CompletedAdaptive COVID-19 Treatment Trial 2 (ACTT-2)ACTT-2 will evaluate the combination of baricitinib and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized.NCT04401579·Birmingham, Alabama and 70 others

WithdrawnCOVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU PatientsThis is a multicenter, open-label, single cohort study of patients with confirmed COVID-19 syndrome who based on clinical judgment require care in an intensive care unit…NCT05040776·Los Angeles, California

CompletedStudy to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy IndividualsThis is a Phase 1/2/3, randomized, placebo-controlled, observer-blind, dose-finding, vaccine candidate-selection, and efficacy study in healthy individuals.NCT04368728·Athens, Alabama and 174 others

CompletedRECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID SymptomsThis study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be…NCT05595369·Birmingham, Alabama and 68 others

CompletedCOVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-CThe primary objectives of this study are: * To determine the proportion of children with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) related death…NCT04588363·Loma Linda, California and 19 others

CompletedProspective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other CoronavirusesThe Biomedical Advanced Research and Development Authority (BARDA) has contracted BioFire Defense (BFDf) to develop the BioFire Emerging Coronavirus (ECoV) Panel, a nucleic acid…NCT07221097·Los Angeles, California and 5 others

Active not recruitingA Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 InfectionThe primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet…NCT06672055·Anniston, Alabama and 144 others

RecruitingRandomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVIDThe overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality…NCT06631287·Tucson, Arizona and 16 others

CompletedA Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of AgeThe primary goal for this study is to evaluate up to 3 dose levels of mRNA-1273 vaccine given to healthy children as intramuscular (IM) injection in 2 doses (in Parts 1 and 2) and…NCT04796896·Birmingham, Alabama and 90 others

RecruitingEPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseaseThe purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after…NCT05261139·Phoenix, Arizona and 72 others

Page 1 of 2Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia